TY  - JOUR
AU  - Prats-Martin, Concepcion
AU  - Burillo-Sanz, Sergio
AU  - Morales-Camacho, Rosario M
AU  - Perez-Lopez, Olga
AU  - Suito, Milagros
AU  - Vargas, Maria T
AU  - Caballero-Velazquez, Teresa
AU  - Carrillo-Cruz, Estrella
AU  - Gonzalez, Jose
AU  - Bernal, Ricardo
AU  - Perez-Simon, Jose A
PY  - 2020
DO  - 10.1002/cam4.2947
UR  - http://hdl.handle.net/10668/15288
T2  - Cancer medicine
AB  - Acute myeloid leukemia with myelodysplasia-related changes (AML-MRC) are poor outcome leukemias. Its diagnosis is based on clinical, cytogenetic, and cytomorphologic criteria, last criterion being sometimes difficult to assess. A high frequency of...
LA  - en
PB  - John Wiley & Sons Ltd.
KW  - ASXL1
KW  - AML-MRC
KW  - myelodysplasia
KW  - myeloid leukemia
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Biomarkers, Tumor
KW  - Bone Marrow
KW  - Case-Control Studies
KW  - Chromosome Aberrations
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Karyotype
KW  - Leukemia, Myeloid, Acute
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Myelodysplastic Syndromes
KW  - Prognosis
KW  - Repressor Proteins
KW  - Survival Rate
TI  - ASXL1 mutation as a surrogate marker in acute myeloid leukemia with myelodysplasia-related changes and normal karyotype.
TY  - research article
VL  - 9
ER  -